Featured Research

from universities, journals, and other organizations

Protein that keeps stem cells poised for action identified

Date:
December 28, 2009
Source:
Stanford University Medical Center
Summary:
Researchers have now identified a critical component, called Jarid2, of this delicate balancing act -- one that both recruits other regulatory proteins to genes important in differentiation and also modulates their activity to keep them in a state of ongoing readiness.

Like a child awaiting the arrival of Christmas, embryonic stem cells exist in a state of permanent anticipation. They must balance the ability to quickly become more specialized cell types with the cellular chaos that could occur should they act too early (stop shaking those presents, kids!). Researchers at the Stanford University School of Medicine have now identified a critical component, called Jarid2, of this delicate balancing act -- one that both recruits other regulatory proteins to genes important in differentiation and also modulates their activity to keep them in a state of ongoing readiness.

"Understanding how only the relevant genes are targeted and remain poised for action is a hot topic in embryonic stem cell research," said Joanna Wysocka, PhD, assistant professor of developmental biology and of chemical and systems biology. "Our results shed light on both these questions." Wysocka is the lead author of the research, which will be published in the Dec. 24 issue of Cell.

Jarid2 works through a protein complex called PRC2, for Polycomb Repressive Complex 2. PRCs keep genes quiet by modifying DNA packaging proteins called histones. It's not quite tying a string around a brown paper package, but the concept is similar: Wrapping DNA up neatly around the histones helps it all fit in the tiny space and keeps it out of commission until the appropriate time. That's because, when wrapped, genes can't be converted into proteins to do the work of the cell. PRC2 adds a molecular "Do not open until Christmas" tag to ensure the DNA stays wrapped until it's needed.

PRC2 is necessary to regulate the expression of developmentally important genes in many types of cells. But Wysocka and her colleagues wanted to know specifically how it worked in embryonic stem cells. When they looked in mouse embryonic stem cells, they found that nearly all PRC2 is bound to a protein called Jarid2, which is more prevalent in embryonic stem cells than in non-stem cells.

Jarid2 had been previously identified as a protein important during development. But its role in embryonic stem cells hadn't yet been addressed. The Stanford researchers found that together PRC2 and Jarid2 occupied specific stretches of histone-bound DNA in both mouse and human embryonic stem cells. When they reduced the amount of Jarid2 in the cells, PRC2 was less able to bind the DNA and the cell began to churn out the proteins before they were needed -- confirming Jarid2's importance in stem cell differentiation.

Surprisingly, though, the degree of modifications on the histones remained about the same, even though less PRC2 was bound to the DNA. This suggested that when PRC2 is bound to Jarid2, it puts fewer "don't open" tags on the histones.

"This was a crucial finding," said Wysocka, "because it shows that Jarid2 both recruits PRC2 to the DNA and modulates its ability to modify the histones." It also suggests that the Jarid2/PRC2 complex inhibits gene expression in other, as-yet-unidentified ways. Such fine-tuning of PRC2 activity, the researchers believe, allows the cell to carefully manage its degree of readiness for the subsequent unwrapping and expression of genes involved in differentiation of the embryonic stem cells into more specialized cells.

The researchers confirmed their findings in frog embryos, which are more easily studied at early stages of differentiation than are mouse embryos, by depleting Jarid2 expression. They found that embryos missing Jarid2 were unable to complete a critically important developmental step called gastrulation.

"It was just as we would have predicted," said Wysocka. "Without Jarid2, which keeps the genes silent yet poised for activation, the embryos stop developing." The researchers now plan to further investigate the mechanism by which Jarid2 summons PRC2 to differentiation-specific genes in the stem cells, and how it affects gene expression. The interaction may be important in human cancers as well. "PRC2 is upregulated in some cancers," noted Wysocka, "which may help keep these cells in an undifferentiated, rapidly proliferating state. It will be interesting to see whether Jarid2 is also expressed at high levels in these diseases. There are all sorts of implications for stem cell biology, differentiation and human disease."

In addition to Wysocka, other Stanford scientists involved in the research include postdoctoral scholars Jamy Peng, PhD, and Anton Valouev, PhD; senior research scientist Tomek Swigut, PhD; and associate professor of pathology and of genetics Arend Sidow, PhD.

The research was supported by the California Institute for Regenerative Medicine, the W.M. Keck Distinguished Young Scholar and Searle Scholar Awards, the American Cancer Society and the National Institutes of Health.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Stanford University Medical Center. "Protein that keeps stem cells poised for action identified." ScienceDaily. ScienceDaily, 28 December 2009. <www.sciencedaily.com/releases/2009/12/091227212317.htm>.
Stanford University Medical Center. (2009, December 28). Protein that keeps stem cells poised for action identified. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2009/12/091227212317.htm
Stanford University Medical Center. "Protein that keeps stem cells poised for action identified." ScienceDaily. www.sciencedaily.com/releases/2009/12/091227212317.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins